v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,899.9 $ 1,697.2
Marketable investments 1,421.4 1,569.8
Accounts receivable, no allowance for 2025 and 2024 322.0 279.3
Inventories, net 165.4 157.9
Other current assets 131.1 169.7
Total current assets 3,939.8 3,873.9
Marketable investments 1,710.7 1,475.3
Goodwill and other intangible assets, net 111.7 111.9
Property, plant, and equipment, net 1,302.7 1,222.4
Deferred tax assets, net 456.6 458.4
Other non-current assets 222.4 222.1
Total assets 7,743.9 7,364.0
Current liabilities:    
Accounts payable and accrued expenses 367.0 344.5
Line of credit 200.0 300.0
Other current liabilities 154.5 93.6
Total current liabilities 721.5 738.1
Other non-current liabilities 215.2 181.9
Total liabilities 936.7 920.0
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, par value $.01, 10,000,000 shares authorized, no shares issued 0.0 0.0
Common stock, par value $.01, 245,000,000 shares authorized, 75,241,141 and 74,997,896 shares issued, and 45,074,551 and 44,831,306 shares outstanding as of March 31, 2025 and December 31, 2024, respectively 0.8 0.8
Additional paid-in capital 2,737.7 2,698.9
Accumulated other comprehensive loss (1.2) (3.4)
Treasury stock, 30,166,590 shares as of March 31, 2025 and December 31, 2024, respectively (3,474.5) (3,474.5)
Retained earnings 7,544.4 7,222.2
Total stockholders’ equity 6,807.2 6,444.0
Total liabilities and stockholders’ equity $ 7,743.9 $ 7,364.0